New shot aims to boost weight loss for diabetics
NCT ID NCT06851858
Summary
This study is testing if a new weekly injection called AZD6234 can help people with type 2 diabetes and obesity lose more weight. It will be given alongside their current GLP-1 medication (like Ozempic or Wegovy). The main goal is to see if adding AZD6234 leads to greater weight loss after 26 weeks compared to adding a placebo (dummy injection).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Birmingham, Alabama, 35205, United States
-
Research Site
Mobile, Alabama, 36608, United States
-
Research Site
Doral, Florida, 33166, United States
-
Research Site
Jacksonville, Florida, 32216, United States
-
Research Site
Miami, Florida, 33135, United States
-
Research Site
Miami, Florida, 33136, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Canton, Georgia, 30114, United States
-
Research Site
Fayetteville, Georgia, 30214, United States
-
Research Site
Chicago, Illinois, 60640, United States
-
Research Site
Oak Brook, Illinois, 60523, United States
-
Research Site
Newton, Kansas, 67114, United States
-
Research Site
Lexington, Kentucky, 40509, United States
-
Research Site
Kansas City, Missouri, 64114, United States
-
Research Site
Las Vegas, Nevada, 89119, United States
-
Research Site
Norman, Oklahoma, 73069, United States
-
Research Site
Knoxville, Tennessee, 37909, United States
-
Research Site
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.